Baricitinib vs Erlotinib

Baricitinib vs Erlotinib: Overview

This comparison examines the pharmacological differences between Baricitinib and Erlotinib.

Mechanism of Action

Baricitinib: Selective JAK1 and JAK2 inhibitor blocking cytokine signaling involved in inflammation.

Erlotinib: Reversible inhibitor of EGFR (HER1) tyrosine kinase, blocking autophosphorylation.

Pharmacokinetics

Half-life: Baricitinib — 12 hours; Erlotinib — 36 hours.

Chemical Properties

Molecular Formula: Baricitinib — C16H17N7O2S; Erlotinib — C22H23N3O4.

Molecular Weight: Baricitinib — 371.4170 g/mol; Erlotinib — 393.4380 g/mol.

Type: Baricitinib — Small molecule; Erlotinib — Small molecule.